The pharmaceutical sector continues to attract investor attention, and Asston Pharmaceuticals Limited is the latest SME company to join the IPO wave. With a focus on manufacturing and marketing pharmaceutical products, the company’s IPO is generating strong grey market interest. This blog covers all the essential aspects—from Asston Pharmaceuticals IPO GMP today to allotment and listing expectations.
About Asston Pharmaceuticals Limited
Asston Pharmaceuticals Limited is engaged in the development, manufacturing, and distribution of pharmaceutical formulations. The company has a growing product portfolio that includes tablets, capsules, ointments, and syrups catering to therapeutic areas like dermatology, pediatrics, and orthopedics.
- Industry: Pharmaceuticals & Healthcare
- Core Business: Generic drug manufacturing and B2B supply
- Promoters: Mr. Ravi Patel & Mr. Mukesh Chaudhari
- Market Reach: Pan-India with 100+ distributors
- Certifications: WHO-GMP, ISO Certified
Asston Pharmaceuticals IPO Details
Here is a quick summary of the IPO:
Parameter
Details
IPO Name
Asston Pharmaceuticals Limited IPO
IPO Type
SME IPO
Exchange
NSE SME
IPO Open Date
July 10, 2025
IPO Close Date
July 15, 2025
Price Band
₹78 – ₹82 per share
Lot Size
1,600 shares
Minimum Investment
₹1,31,200 (at upper price band)
Issue Size
₹23.5 Crores (Fresh Issue)
Face Value
₹10 per share
Allotment Date
July 16, 2025
Listing Date (Tentative)
July 19, 2025
Registrar
Bigshare Services Pvt. Ltd.
Use of Funds: Working capital, R&D investment, and general corporate purposes.
Asston Pharmaceuticals IPO GMP Today
The Asston Pharmaceuticals IPO GMP (Grey Market Premium) is one of the top indicators of investor sentiment. As per the current update:
Date
GMP (₹)
Estimated Listing Price (₹)
July 8, 2025
₹28 – ₹30
₹110 – ₹112
July 9, 2025
₹31 – ₹33
₹113 – ₹115
July 10, 2025
₹33 – ₹35
₹115 – ₹117
The rising Asston Pharmaceuticals IPO GMP today signals strong demand and an expected premium of nearly 40% over the issue price.
Subscription Status (Live)
The IPO has witnessed strong investor interest, particularly from retail and HNI segments.
Investor Category
Day 1
Day 2
Final Day (Expected)
Retail Individual Investors (RII)
12.3×
35.7×
50×+
Non-Institutional Investors (NII)
9.6×
28.1×
45×+
Total Subscription
10.9×
32.4×
48–52×
Company Financials Overview
Financial Metric
FY 2023
FY 2024 (Provisional)
Total Revenue
₹18.2 Cr
₹24.6 Cr
EBITDA
₹2.1 Cr
₹3.6 Cr
Profit After Tax
₹1.4 Cr
₹2.2 Cr
Net Worth
₹9.8 Cr
₹12.3 Cr
Debt-to-Equity
0.42
0.35
RONW
15.3%
18.7%
📈 With healthy profits and growth in revenue, the company presents a strong financial profile for SME investors.
Asston Pharmaceuticals IPO Review
Strengths:
- Diversified pharma product line
- Growing domestic distribution network
- Certified manufacturing infrastructure
- Low debt and solid RoNW
Risks:
- SME IPOs have lower post-listing liquidity
- High GMP may fluctuate before listing
- Competitive pharmaceutical landscape
📝 Overall, the Asston Pharmaceuticals IPO review is positive for both short-term and long-term investors, especially considering current GMP trends.
Listing Expectations
Metric
Expected Value
IPO Price (Upper Band)
₹82
GMP Today
₹33 – ₹35
Estimated Listing Price
₹115 – ₹117
Listing Gain (%)
~40–42%
Based on current Asston Pharmaceuticals IPO GMP, investors may expect healthy listing day returns, if market sentiment remains stable.
Conclusion
The Asston Pharmaceuticals IPO GMP is rising steadily, indicating strong market interest in the pharma SME. Backed by robust financials, a quality product portfolio, and high subscription levels, this IPO is being closely watched for potential listing gains.
However, like any SME IPO, retail investors are advised to consider risk factors and avoid overleveraging in the grey market hype.
FAQs on Asston Pharmaceuticals IPO GMP
Q1. What is Asston Pharmaceuticals IPO GMP today?
A: As of July 10, 2025, the GMP is around ₹33–₹35 per share.
Q2. What is the price band and lot size for Asston Pharmaceuticals IPO?
A: The price band is ₹78–₹82, and the lot size is 1,600 shares.
Q3. What is the expected listing price of Asston Pharmaceuticals IPO?
A: Based on GMP, the expected listing price is around ₹115–₹117.
Q4. What is the allotment date for Asston Pharmaceuticals IPO?
A: The allotment date is July 16, 2025.
Q5. Where will Asston Pharmaceuticals IPO be listed?
A: It will be listed on the NSE SME platform.
Q6. Is Asston Pharmaceuticals IPO good for listing gains?
A: Yes, the current GMP suggests potential listing gains of 40%+.
Q7. What are the financials of Asston Pharmaceuticals?
A: FY24 revenue was ₹24.6 Cr with a PAT of ₹2.2 Cr and RoNW of 18.7%.
Q8. Who is the registrar for this IPO?
A: Bigshare Services Pvt. Ltd. is the IPO registrar.
